Cargando…

Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein

Conjugation chemistry is one of the main parameters affecting immunogenicity of glycoconjugate vaccines and a rational approach toward a deeper understanding of their mechanism of action will greatly benefit from highly-defined and well-characterized structures. Herein, different conjugation methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefanetti, G., Allan, M., Usera, A., Micoli, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501094/
https://www.ncbi.nlm.nih.gov/pubmed/32535667
http://dx.doi.org/10.1007/s10719-020-09930-2
_version_ 1783583984402300928
author Stefanetti, G.
Allan, M.
Usera, A.
Micoli, F.
author_facet Stefanetti, G.
Allan, M.
Usera, A.
Micoli, F.
author_sort Stefanetti, G.
collection PubMed
description Conjugation chemistry is one of the main parameters affecting immunogenicity of glycoconjugate vaccines and a rational approach toward a deeper understanding of their mechanism of action will greatly benefit from highly-defined and well-characterized structures. Herein, different conjugation methods were investigated with the aim of controlling glycosylation site and glycosylation density on the carrier protein. S. Typhimurium lipopolysaccharide O-Antigen and CRM(197) carrier protein were used as models. In particular, thiol and click chemistry were examined, both involving the linkage of the terminal reducing sugar unit of the O-Antigen chain to different amino acids on the carrier protein. Thiol chemistry allowed O-Antigen conjugation only when the carrier protein was activated on the lysines and with a relative high number of linkers, while click chemistry allowed conjugate generation even when just one position on the protein was activated and to both lysine and tyrosine sites. The study highlights click chemistry as a leading approach for the synthesis of well-defined glycoconjugates, useful to investigate the relationship between conjugate design and immune response.
format Online
Article
Text
id pubmed-7501094
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-75010942020-10-01 Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein Stefanetti, G. Allan, M. Usera, A. Micoli, F. Glycoconj J Original Article Conjugation chemistry is one of the main parameters affecting immunogenicity of glycoconjugate vaccines and a rational approach toward a deeper understanding of their mechanism of action will greatly benefit from highly-defined and well-characterized structures. Herein, different conjugation methods were investigated with the aim of controlling glycosylation site and glycosylation density on the carrier protein. S. Typhimurium lipopolysaccharide O-Antigen and CRM(197) carrier protein were used as models. In particular, thiol and click chemistry were examined, both involving the linkage of the terminal reducing sugar unit of the O-Antigen chain to different amino acids on the carrier protein. Thiol chemistry allowed O-Antigen conjugation only when the carrier protein was activated on the lysines and with a relative high number of linkers, while click chemistry allowed conjugate generation even when just one position on the protein was activated and to both lysine and tyrosine sites. The study highlights click chemistry as a leading approach for the synthesis of well-defined glycoconjugates, useful to investigate the relationship between conjugate design and immune response. Springer US 2020-06-13 2020 /pmc/articles/PMC7501094/ /pubmed/32535667 http://dx.doi.org/10.1007/s10719-020-09930-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Stefanetti, G.
Allan, M.
Usera, A.
Micoli, F.
Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein
title Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein
title_full Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein
title_fullStr Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein
title_full_unstemmed Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein
title_short Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein
title_sort click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using crm(197) as carrier protein
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501094/
https://www.ncbi.nlm.nih.gov/pubmed/32535667
http://dx.doi.org/10.1007/s10719-020-09930-2
work_keys_str_mv AT stefanettig clickchemistrycomparedtothiolchemistryforthesynthesisofsiteselectiveglycoconjugatevaccinesusingcrm197ascarrierprotein
AT allanm clickchemistrycomparedtothiolchemistryforthesynthesisofsiteselectiveglycoconjugatevaccinesusingcrm197ascarrierprotein
AT useraa clickchemistrycomparedtothiolchemistryforthesynthesisofsiteselectiveglycoconjugatevaccinesusingcrm197ascarrierprotein
AT micolif clickchemistrycomparedtothiolchemistryforthesynthesisofsiteselectiveglycoconjugatevaccinesusingcrm197ascarrierprotein